Stay updated on Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page.

Latest updates to the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe revision tag on the page changed from v3.6.2 to v3.6.3. This reflects a minor version update and does not modify study details or user actions.SummaryDifference0.0%

- Check18 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a backend update; the change does not alter displayed trial information.SummaryDifference0.0%

- Check33 days agoChange DetectedRecruitment status now indicates no longer looking for participants. New navigation and help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, the Intervention/Treatment header formatting was adjusted, and the page revision was updated to v3.6.0.SummaryDifference0.3%

- Check40 days agoChange DetectedThe page’s revision number was updated from v3.5.4 to v3.5.5, indicating a minor update to the record’s metadata.SummaryDifference0.0%

- Check61 days agoChange DetectedPublications entries were updated. The Sharma et al. CheckMate 032 Lancet Oncology paper was added with its citation, and the prior erratum reference was replaced with a revised entry (version 3.5.4).SummaryDifference0.1%

- Check76 days agoChange DetectedThe page now displays a new revision label (v3.5.3) replacing the previous v3.5.2, indicating a software update to the page.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page.